CN1787811A - 口腔崩解片 - Google Patents

口腔崩解片 Download PDF

Info

Publication number
CN1787811A
CN1787811A CN200480013099.3A CN200480013099A CN1787811A CN 1787811 A CN1787811 A CN 1787811A CN 200480013099 A CN200480013099 A CN 200480013099A CN 1787811 A CN1787811 A CN 1787811A
Authority
CN
China
Prior art keywords
tablet
tablet according
microcrystalline cellulose
active agent
orally disintegrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200480013099.3A
Other languages
English (en)
Chinese (zh)
Inventor
J·J·普拉特沃
D·J·M·范登赫沃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthon BV
Original Assignee
Synthon BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon BV filed Critical Synthon BV
Publication of CN1787811A publication Critical patent/CN1787811A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN200480013099.3A 2003-04-16 2004-04-16 口腔崩解片 Pending CN1787811A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46302703P 2003-04-16 2003-04-16
US60/463,027 2003-04-16

Publications (1)

Publication Number Publication Date
CN1787811A true CN1787811A (zh) 2006-06-14

Family

ID=33300032

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200480013099.3A Pending CN1787811A (zh) 2003-04-16 2004-04-16 口腔崩解片

Country Status (10)

Country Link
US (1) US20040265375A1 (https=)
EP (1) EP1613289A1 (https=)
JP (1) JP2006524650A (https=)
CN (1) CN1787811A (https=)
AU (1) AU2004229177A1 (https=)
CA (1) CA2522100A1 (https=)
NO (1) NO20055393L (https=)
NZ (1) NZ542925A (https=)
WO (1) WO2004091585A1 (https=)
ZA (1) ZA200508361B (https=)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101766605A (zh) * 2008-12-29 2010-07-07 北京德众万全药物技术开发有限公司 包含普拉克索的可在口中分散的药物组合物
CN102727452A (zh) * 2011-04-01 2012-10-17 成都康弘药业集团股份有限公司 一种含右佐匹克隆的颗粒及其制备方法
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
CN104027319A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 一种塞来昔布分散片及其制备方法
CN104161733A (zh) * 2007-07-02 2014-11-26 阿普塔利斯制药股份有限公司 拉莫三嗪的口服崩解片剂组合物
CN104382895A (zh) * 2014-10-22 2015-03-04 湖南明瑞制药有限公司 一种辛伐他汀组合物
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
CN104771761A (zh) * 2015-03-19 2015-07-15 深圳国源国药有限公司 一种创新药用辅料硅化微晶纤维素及其制备方法
CN105012253A (zh) * 2014-04-24 2015-11-04 南京长澳医药科技有限公司 一种盐酸普拉克索口腔崩解片及其制备方法
CN105147627A (zh) * 2015-08-19 2015-12-16 天津红日药业股份有限公司 一种含有盐酸普拉克索的药物组合物及其制备方法
CN105916522A (zh) * 2013-11-22 2016-08-31 建新公司 用于治疗神经变性疾病的新方法
CN106999437A (zh) * 2014-12-25 2017-08-01 株式会社大赛璐 超速崩解片剂及其制备方法
CN108938580A (zh) * 2017-05-26 2018-12-07 万全万特制药江苏有限公司 盐酸帕罗西汀口崩片
CN109864975A (zh) * 2017-12-04 2019-06-11 成都康弘药业集团股份有限公司 一种阿立哌唑的口腔崩解片及其制备方法
CN110840850A (zh) * 2018-07-24 2020-02-28 烟台药物研究所 一种高生物利用度的塞来昔布冻干口崩片及其制备方法
CN111757728A (zh) * 2018-03-11 2020-10-09 纳诺洛吉卡股份公司 用于压缩的药物剂型的多孔二氧化硅颗粒
CN116801888A (zh) * 2020-12-31 2023-09-22 株式会社泰俊制药 用于结肠清洁的口服固体制剂

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
DE60120104T2 (de) 2001-03-20 2006-09-21 Schwarz Pharma Ag Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz
DK1243263T3 (da) 2001-03-21 2003-03-17 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
WO2005034921A1 (en) * 2003-10-07 2005-04-21 Andrx Pharmaceuticals Llc Rapidly disintegrating formulation
ATE522507T1 (de) * 2003-10-10 2011-09-15 Synhton B V Montelukast in fester phase
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
ATE504588T1 (de) * 2004-01-27 2011-04-15 Synthon Bv Stabile salze von olanzapin
JP5179757B2 (ja) 2004-02-17 2013-04-10 トランセプト ファーマシューティカルズ， インコーポレイティド 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
US7501517B2 (en) * 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
DE102004028940A1 (de) * 2004-06-15 2006-01-12 Krka Tovarna Zdravil, D.D. Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
EA014055B1 (ru) 2004-08-27 2010-08-30 Шварц Фарма Аг Применение пептидных соединений для лечения боли при раке кости, а также боли, вызванной химиотерапией и нуклеозидами
US20060078615A1 (en) * 2004-10-12 2006-04-13 Boehringer Ingelheim International Gmbh Bilayer tablet of telmisartan and simvastatin
ATE415148T1 (de) 2004-10-19 2008-12-15 Krka Tovarna Zdravil D D Novo Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
JP2008523044A (ja) * 2004-12-13 2008-07-03 マクニール−ピーピーシー・インコーポレーテツド 医薬品有効成分を安定化する組成物および方法
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
CZ297214B6 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
PL385455A1 (pl) * 2005-04-22 2008-11-24 Teva Pharmaceuticals Usa,Inc. Doustna rozpadająca się farmaceutyczna tabletka preparatów olanzapiny
ZA200710205B (en) * 2005-05-25 2009-03-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
EP1883408A4 (en) * 2005-05-25 2009-11-11 Transcept Pharmaceuticals Inc SOLID COMPOSITIONS AND METHODS FOR TREATMENT OF INSOMNIA IN THE NIGHT
WO2007002518A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
JP2007015966A (ja) * 2005-07-06 2007-01-25 Fujimoto Corporation:Kk 口腔内崩壊錠
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
JP5241681B2 (ja) * 2005-08-01 2013-07-17 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
JP4439499B2 (ja) * 2005-08-01 2010-03-24 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
WO2007018192A1 (ja) * 2005-08-10 2007-02-15 Shionogi & Co., Ltd. 口腔内崩壊錠剤
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
WO2007020080A1 (en) * 2005-08-17 2007-02-22 Synthon B.V. A process for making olanzapine form i
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
FR2891147B1 (fr) * 2005-09-28 2007-12-07 Ethypharm Sa Comprimes orodispersibles de principes actifs amers
US20070093471A1 (en) * 2005-10-26 2007-04-26 Alamo Pharmaceuticals, Llc Compositions and methods for the administration clozapine formulations which modulate body weight
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AR057908A1 (es) * 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar montelukast e intermediarios del mismo
AU2006322314A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
JP2009519334A (ja) * 2005-12-20 2009-05-14 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾール経口崩壊錠剤
CA2632039A1 (en) * 2005-12-23 2007-06-28 Lek Pharmaceuticals D.D. Bursting pellets
EA021960B1 (ru) † 2005-12-30 2015-10-30 Крка, Товарна Здравил, Д.Д., Ново Место Таблетка, содержащая фармацевтически приемлемую соль монтелукаста в аморфной форме, и способ ее получения
CN103211779B (zh) * 2006-01-27 2016-03-16 阿代尔制药股份有限公司 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
RU2428176C2 (ru) * 2006-01-27 2011-09-10 Юранд, Инк. Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты
EP1815857A1 (en) * 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007107297A1 (en) * 2006-03-17 2007-09-27 Synthon B.V. Montelukast amantadine salt
WO2007111375A1 (ja) * 2006-03-24 2007-10-04 Kowa Company, Ltd. 口腔内速崩壊性錠剤
WO2007134845A2 (en) * 2006-05-18 2007-11-29 Synthon B.V. Olanzapine pharmaceutical composition
US20070281014A1 (en) * 2006-06-01 2007-12-06 Cima Labs, Inc. Prednisolone salt formulations
US8637076B2 (en) * 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
EA019757B1 (ru) 2006-06-15 2014-06-30 ЮСиБи ФАРМА ГМБХ Фармацевтическая композиция с синергетическим противосудорожным эффектом
US20080008743A1 (en) * 2006-07-06 2008-01-10 Forest Laboratories Holdings Limited Orally Dissolving Formulations of Memantine
JP2008044870A (ja) * 2006-08-11 2008-02-28 Elmed Eisai Kk 医薬組成物及びその製造方法
CL2007002807A1 (es) * 2006-09-29 2008-04-11 Synthon Bv Composicion farmaceutica en estado solido que comprende olanzapina o una sal farmaceuticamente aceptable de la misma y lactosa anhidra; tableta farmaceutica oral; procedimiento de preparacion de dicha tableta, util en el tratamiento de la esquizofren
WO2008058355A2 (en) * 2006-11-16 2008-05-22 Walter Santos Junior Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases
BRMU8602968U (pt) * 2006-11-16 2008-09-30 Jr Walter Santos medicamento "ramipril + metformina" em forma combinada para doenças cardiovasculares
GB2444904B (en) * 2006-12-05 2008-11-05 Michael Hilary Burke A Process For The Preparation of an Orally Administrable Unit Dose Tablet
TW200835527A (en) * 2006-12-26 2008-09-01 Shionogi & Co Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone
CA2721133C (en) * 2007-04-13 2018-11-06 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations and methods of making and using the same
EP1997480A1 (en) * 2007-06-01 2008-12-03 The Jordanian Pharmaceutical Manufacturing Co. Mineral-fiber solid dispersion, method for preparing the same and use thereof as pharmaceutical tableting aid
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
ES2455195T3 (es) * 2007-11-21 2014-04-14 Dainippon Sumitomo Pharma Co., Ltd. Comprimido que se disgrega en la cavidad oral
RU2010128019A (ru) * 2007-12-08 2012-01-20 Байер Шеринг Фарма Акциенгезельшафт (DE) Пероральная диспергируемая таблетка
JP2009196940A (ja) * 2008-02-22 2009-09-03 Takada Seiyaku Kk 口腔内速崩壊錠及びその製造法
CN102046602A (zh) * 2008-04-25 2011-05-04 斯索恩有限公司 制备孟鲁司特中间体的方法
US20100016265A1 (en) * 2008-07-16 2010-01-21 Qaiser Yusuf Anti-inflammatory composition and method for preparation
JP2012521393A (ja) 2009-03-26 2012-09-13 ロイヤル カレッジ オブ サージェオンズ イン アイルランド 口腔内分散性錠剤
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
CA2773003A1 (en) * 2009-09-15 2011-03-24 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
NZ624922A (en) 2009-10-01 2016-05-27 Adare Pharmaceuticals Inc Orally administered corticosteroid compositions
TR200907554A1 (tr) * 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.
CN102058549B (zh) * 2009-11-17 2014-08-27 北京万全阳光医学技术有限公司 一种含非那雄胺的口腔崩解片及其制备方法
CN101716151B (zh) * 2009-12-24 2012-06-27 杭州康恩贝制药有限公司 一种快速溶出的非那雄胺口服片剂及制备方法
EP2524689B1 (en) * 2009-12-28 2016-10-05 Nipro Corporation Method for producing donepezil tablets
JP2011213695A (ja) * 2010-04-02 2011-10-27 Taisho Pharm Ind Ltd ドネペジル塩酸塩含有口腔内速崩壊錠
US8703203B2 (en) * 2010-07-08 2014-04-22 Ratiopharm Gmbh Oral dosage form of deferasirox
CA2816957A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
EP2468254A1 (en) * 2010-12-15 2012-06-27 Hexal AG Orally disintegrating tablet having a taste masking effect
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
JP6062693B2 (ja) * 2012-09-14 2017-01-18 沢井製薬株式会社 オランザピン含有製剤
WO2014090386A1 (en) * 2012-12-11 2014-06-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Orally disintegrating tablet containing asenapine
EP2964243B1 (en) 2013-03-06 2022-11-23 Capsugel Belgium NV Curcumin solid lipid particles and methods for their preparation and use
US20150025112A1 (en) * 2013-07-19 2015-01-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablet formulations of donepezil
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104784047B (zh) * 2014-01-16 2018-09-21 南京瑞尔医药有限公司 一种非那雄胺组合物
EP3766480A1 (en) * 2014-06-10 2021-01-20 Capsugel Belgium NV Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
CA3018828C (en) 2014-09-17 2021-05-11 Steerlife India Private Limited Effervescent composition and method of making it
JP2016079120A (ja) * 2014-10-15 2016-05-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 包装により安定性が改善されたオランザピン製剤
US11324699B2 (en) 2014-12-04 2022-05-10 Capsugel Belgium Nv Lipid multiparticulate formulations
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
RU2619213C1 (ru) * 2016-01-25 2017-05-12 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма зафирлукаста немедленного высвобождения и способ ее получения
US11110035B1 (en) 2016-02-05 2021-09-07 Gram Tactical Llc Tactical medicine dispensers
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
AU2019334202A1 (en) 2018-09-06 2021-03-25 Innopharmascreen, Inc. Methods and compositions for treatment of asthma or parkinson's disease
JP7219979B2 (ja) * 2020-02-26 2023-02-09 日新製薬株式会社 被覆層を有する口腔内崩壊錠
GB2636158A (en) * 2023-12-01 2025-06-11 Novumgen Ltd An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US50312A (en) * 1865-10-03 Improvement in handle attachments to small-arms
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6471994B1 (en) * 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
DK2263660T3 (en) * 1998-05-18 2018-01-02 Takeda Pharmaceuticals Co Orally disintegrating tablets.
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
KR20020062323A (ko) * 1999-12-06 2002-07-25 펜웨스트 파머슈티칼즈 컴파니 제약학적 초붕해제
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
BR0206164A (pt) * 2001-07-31 2003-10-28 Lundbeck & Co As H Partìculas cristalinas de oxalato de escitalopram, método para a produção de partìculas cristalinas de oxalato de escitalopram, e, forma de dosagem unitária sólida
MXPA04007428A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
CN104161733A (zh) * 2007-07-02 2014-11-26 阿普塔利斯制药股份有限公司 拉莫三嗪的口服崩解片剂组合物
CN101766605A (zh) * 2008-12-29 2010-07-07 北京德众万全药物技术开发有限公司 包含普拉克索的可在口中分散的药物组合物
CN101766605B (zh) * 2008-12-29 2014-02-19 北京德众万全药物技术开发有限公司 包含普拉克索的可在口中分散的药物组合物
CN102727452A (zh) * 2011-04-01 2012-10-17 成都康弘药业集团股份有限公司 一种含右佐匹克隆的颗粒及其制备方法
CN102727452B (zh) * 2011-04-01 2014-12-24 成都康弘药业集团股份有限公司 一种含右佐匹克隆的颗粒及其制备方法
CN105916522A (zh) * 2013-11-22 2016-08-31 建新公司 用于治疗神经变性疾病的新方法
CN105012253A (zh) * 2014-04-24 2015-11-04 南京长澳医药科技有限公司 一种盐酸普拉克索口腔崩解片及其制备方法
CN104027319A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 一种塞来昔布分散片及其制备方法
CN104382895A (zh) * 2014-10-22 2015-03-04 湖南明瑞制药有限公司 一种辛伐他汀组合物
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
TWI731846B (zh) * 2014-12-25 2021-07-01 日商大賽璐股份有限公司 超高速崩解錠劑及其製造方法
CN106999437A (zh) * 2014-12-25 2017-08-01 株式会社大赛璐 超速崩解片剂及其制备方法
CN104771761A (zh) * 2015-03-19 2015-07-15 深圳国源国药有限公司 一种创新药用辅料硅化微晶纤维素及其制备方法
CN105147627A (zh) * 2015-08-19 2015-12-16 天津红日药业股份有限公司 一种含有盐酸普拉克索的药物组合物及其制备方法
CN105147627B (zh) * 2015-08-19 2019-04-12 天津红日药业股份有限公司 一种含有盐酸普拉克索的药物组合物及其制备方法
CN108938580A (zh) * 2017-05-26 2018-12-07 万全万特制药江苏有限公司 盐酸帕罗西汀口崩片
CN108938580B (zh) * 2017-05-26 2022-09-27 万全万特制药江苏有限公司 盐酸帕罗西汀口崩片
CN109864975A (zh) * 2017-12-04 2019-06-11 成都康弘药业集团股份有限公司 一种阿立哌唑的口腔崩解片及其制备方法
CN109864975B (zh) * 2017-12-04 2021-10-08 成都康弘药业集团股份有限公司 一种阿立哌唑的口腔崩解片及其制备方法
CN111757728A (zh) * 2018-03-11 2020-10-09 纳诺洛吉卡股份公司 用于压缩的药物剂型的多孔二氧化硅颗粒
CN110840850A (zh) * 2018-07-24 2020-02-28 烟台药物研究所 一种高生物利用度的塞来昔布冻干口崩片及其制备方法
CN116801888A (zh) * 2020-12-31 2023-09-22 株式会社泰俊制药 用于结肠清洁的口服固体制剂

Also Published As

Publication number Publication date
NZ542925A (en) 2007-04-27
WO2004091585A1 (en) 2004-10-28
US20040265375A1 (en) 2004-12-30
NO20055393D0 (no) 2005-11-15
NO20055393L (no) 2006-01-16
EP1613289A1 (en) 2006-01-11
CA2522100A1 (en) 2004-10-28
JP2006524650A (ja) 2006-11-02
AU2004229177A1 (en) 2004-10-28
ZA200508361B (en) 2006-12-27

Similar Documents

Publication Publication Date Title
CN1787811A (zh) 口腔崩解片
CN1222317C (zh) 可迅速崩解的压模物质及其生产方法
JP6014044B2 (ja) 迅速分散顆粒、口腔内崩壊錠、および方法
CN1136853C (zh) 含β-内酰胺抗生素的片剂及其制备方法
CN1638803A (zh) 口腔内速崩解性片剂
KR101099176B1 (ko) 구강내 속붕성 정제
CN1494418A (zh) 口腔内快速崩解片剂
WO2007074856A1 (ja) 口腔内崩壊性固形製剤の製造法
JP7336388B2 (ja) 錠剤及びその製造方法
CN1747723A (zh) 含活性成分混合物的组合物及其制备方法
CN102548542A (zh) 含有两种以上粒子的口腔速崩片
CN1469737A (zh) 口腔内快速崩解的药用组合物及其制备方法
JPWO2005055989A1 (ja) 薬物含有粒子および該粒子を含む固形製剤
CN1494434A (zh) 含糖醇喷雾干燥粉末的用途
CN1993112A (zh) 用于具有高度pH依赖性溶解度的活性成分的控释的药物多层片剂
CN1303280A (zh) 氟西汀及其对映体的稳定剂型
CN1842331A (zh) 含有氨磺必利的新颖固体药物组合物
WO2005051350A2 (en) Water dispersible tablet
CN1681485A (zh) 莫达非尼的新药物剂型
JP5572321B2 (ja) 被覆微粒子含有口腔内崩壊錠
JP5280420B2 (ja) ナフトピジルを含有する医薬の製造方法
CN1634087A (zh) 复方氨基葡萄糖盐缓释制剂及其制备方法和应用
JP5208348B2 (ja) ナフトピジルを含有する医薬
US20110038928A1 (en) Orally disintegrating tablets of zolmitriptan
JP2019089758A (ja) セレコキシブ含有錠剤における溶出性の改善方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned